Literature DB >> 21787809

Signal integration, crosstalk mechanisms and networks in the function of inflammatory cytokines.

M Lienhard Schmitz1, Axel Weber, Thomas Roxlau, Matthias Gaestel, Michael Kracht.   

Abstract

Infection or cell damage triggers the release of pro-inflammatory cytokines such as interleukin(IL)-1α or β and tumor necrosis factor (TNF)α which are key mediators of the host immune response. Following their identification and the elucidation of central signaling pathways, recent results show a highly complex crosstalk between various cytokines and their signaling effectors. The molecular mechanisms controlling signaling thresholds, signal integration and the function of feed-forward and feedback loops are currently revealed by combining methods from biochemistry, genetics and in silico analysis. Increasing evidence is mounted that defects in information processing circuits or their components can be causative for chronic or overshooting inflammation. As progress in biosciences has always benefitted from the use of well-studied model systems, research on inflammatory cytokines may function as a paradigm to reveal general principles of signal integration, crosstalk mechanisms and signaling networks.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21787809     DOI: 10.1016/j.bbamcr.2011.06.019

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  30 in total

1.  Spatiotemporal control of gene expression boundaries using a feedforward loop.

Authors:  Prasad U Bandodkar; Hadel Al Asafen; Gregory T Reeves
Journal:  Dev Dyn       Date:  2020-01-23       Impact factor: 3.780

Review 2.  Food as medicine: targeting the uraemic phenotype in chronic kidney disease.

Authors:  Denise Mafra; Natalia A Borges; Bengt Lindholm; Paul G Shiels; Pieter Evenepoel; Peter Stenvinkel
Journal:  Nat Rev Nephrol       Date:  2020-09-22       Impact factor: 28.314

3.  Modeling cytokine regulatory network dynamics driving neuroinflammation in central nervous system disorders.

Authors:  Warren D Anderson; Rajanikanth Vadigepalli
Journal:  Drug Discov Today Dis Models       Date:  2017-04-10

4.  Role of heterogeneous cell population on modulation of dendritic cell phenotype and activation of CD8 T cells for use in cell-based immunotherapies.

Authors:  Hannah Frizzell; Jaehyung Park; Natacha Comandante Lou; Kim A Woodrow
Journal:  Cell Immunol       Date:  2016-10-13       Impact factor: 4.868

5.  The potential curative effect of rebamipide in hepatic ischemia/reperfusion injury.

Authors:  Abdallah M Gendy; Dalaal M Abdallah; Hanan S El-Abhar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-03-30       Impact factor: 3.000

6.  TNFα-induced DLK activation contributes to apoptosis in the beta-cell line HIT.

Authors:  Svenja Börchers; Rohollah Babaei; Catarina Klimpel; Jorge Duque Escobar; Sabine Schröder; Roland Blume; Muhammad Nasir Hayat Malik; Elke Oetjen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-05-27       Impact factor: 3.000

Review 7.  Immune mediators in the brain and peripheral tissues in autism spectrum disorder.

Authors:  Myka L Estes; A Kimberley McAllister
Journal:  Nat Rev Neurosci       Date:  2015-08       Impact factor: 34.870

8.  Uncoupling the Senescence-Associated Secretory Phenotype from Cell Cycle Exit via Interleukin-1 Inactivation Unveils Its Protumorigenic Role.

Authors:  Lena Lau; Angelo Porciuncula; Alex Yu; Yoichiro Iwakura; Gregory David
Journal:  Mol Cell Biol       Date:  2019-05-28       Impact factor: 4.272

Review 9.  Bioanalytical chemistry of cytokines--a review.

Authors:  Julie A Stenken; Andreas J Poschenrieder
Journal:  Anal Chim Acta       Date:  2014-10-12       Impact factor: 6.558

10.  Regulation of NF-κB signalling by the mono-ADP-ribosyltransferase ARTD10.

Authors:  Patricia Verheugd; Alexandra H Forst; Larissa Milke; Nicolas Herzog; Karla L H Feijs; Elisabeth Kremmer; Henning Kleine; Bernhard Lüscher
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.